WallStreetZenWallStreetZen

NASDAQ: MIRM
Mirum Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Mirum Pharmaceuticals earnings were -$798.8M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest MIRM earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$790.2M, up 13,689.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MIRM reported annual earnings of -$23.4M, with -73.4% growth.

MIRM earnings history

Current Revenue
$569.6M
Current Earnings
-$798.8M
Current Profit Margin
-140.2%

MIRM Return on Equity

Current Company
-289.3%
Current Industry
-146.3%
Current Market
5.2%
MIRM's Return on Equity (-289.3%)... subscribe to Premium to read more.
High Return on Equity Performance

MIRM Return on Assets

Current Company
-98.5%
Current Industry
-12.4%
MIRM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MIRM announces earnings.

MIRM Return on Capital Employed

Current Company
-126.69%
Current Industry
-8.8%
MIRM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MIRM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MIRM-$756.09M-$798.84MN/A-$13.61
RYTM-$180.75M-$207.84MN/A-$3.13
CNTA-$237.11M-$250.64MN/A-$1.79
APGE-$268.92M-$274.62MN/A-$4.33
CORT-$6.87M$46.67M-11.76%$0.46
View Top Biotech Stocks

Mirum Pharmaceuticals Earnings Reports & History FAQ

What were Mirum Pharmaceuticals's earnings last quarter?

Mirum Pharmaceuticals (NASDAQ: MIRM) reported Q1 2026 earnings per share (EPS) of -$13.43, up 4,376.67% year over year. Total MIRM earnings for the quarter were -$790.16 million. In the same quarter last year, Mirum Pharmaceuticals's earnings per share (EPS) was -$0.30.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.

Is Mirum Pharmaceuticals profitable or losing money?

As of the last Mirum Pharmaceuticals earnings report, Mirum Pharmaceuticals is currently losing money. Mirum Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$798.84 million, a 932.9% increase year over year.

What was MIRM's earnings growth in the past year?

As of Mirum Pharmaceuticals's earnings date in Q2 2026, Mirum Pharmaceuticals's earnings has grown year over year. MIRM earnings in the past year totalled -$798.84 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.